An ultrasonic sensor is provided in which, after output of an excitation signal from a transmission circuit to a drive electrode is stopped, when a suppression control signal subjected to signal amplification by a band variable calculation amplifier is supplied from a reverberant vibration suppression circuit to the drive electrode, reverberant vibration of a piezoelectric body is reduced or prevented in a reverberation suppression time period. In a reception time period after output of the suppression control signal to the drive electrode is stopped, a signal amplification frequency band of the band variable calculation amplifier is varied by a control circuit, and a signal amplification factor of the band variable calculation amplifier in a frequency band of high-frequency noise that occurs within the band variable calculation amplifier is reduced.

Disclosed herein are acoustic transmission systems comprising an acoustic wave generator configured to generate an acoustic wave and propagate the acoustic wave through a tissue of a specimen, and a non-Hermitian complementary metamaterial (NHCMM) configured to add a first amount of energy amplification coherently to the acoustic wave to account for energy loss in the acoustic wave as a result of the wave propagating through the tissue of the specimen. The acoustic wave generator can be an ultrasound generator, and the tissue can be a cranium.

For transducer connection to an integrated circuit, a silicon or other wafer-based chip is processed to provide signal routing, such as altering the pitch using wafer process deposited conductors. This chip or silicon interposer may be more simply re-designed to relate the pitch of an array to the integrated circuit I/Os, avoiding redesign of the integrated circuit.

Embodiments include a primary short circuit coupled to a primary side of a transformer and a dampening element, coupled to a transducer coupled to a secondary side of the transformer, configured to dampen a received signal during a portion of a reverberation period.

System for inducing sonoporation of a drug into cancer cells in a tumor and method thereof, the system comprising a generator configured to provide electrical energy at an ultrasound frequency; an ultrasound probe electrically connected to the generator and configured to convert the electrical energy into low intensity pulsed ultrasonic waves defined by operation parameters, said operation parameters comprising the frequency, the duty cycle, the operation time of the ultrasonic waves; an input device enabling an operator to enter configuration data comprising: type of tumor, type of drug, localization of secondary tumor, anthropometric measurements and grade of tumor, and a processor configured to determine the values of the operation parameters on the basis of the entered configuration data and control the generator and the ultrasound probe to operate according to said determined values, wherein the value of the frequency is determined on the basis of the type of tumor, the localization of the tumor, the grade of tumor and the anthropometric measurements, the value of the duty cycle is determined on the basis of the drug, the type of tumor and the grade of the tumor, and the value of said operation time being determined on the basis of at least the type of tumor and the type of drug.

A self-oscillating piezoelectric actuator drive circuit includes a integrating circuit; an inverter (INV1), inverters (INV2 and INV3) inverting an output signal of the inverter (INV1), sense resistors (Rs1 and Rs2) connected to output sides of the inverters (INV2 and INV3), a positive feedback resistor (Rfb2) feeding back an output signal of the inverters (INV2 and INV3) to the integrating circuit; and a negative feedback resistor (Rfb1) feeding back a voltage generated from the sense resistors (Rs1 and Rs2, Rs1<Rs2 in terms of a resistance value) to the integrating circuit. In a startup state, the sense resistor (Rs2) and the inverter (INV3) are selected, and in an operating state after the startup state, the sense resistor (Rs1) and the inverter (INV2) are selected.

The invention discloses microparticle multi-channel time-sharing separation device and method based on an arcuate interdigital transducer. An arcuate interdigitated electrode is connected to an output channel of a signal generator. The arcuate interdigitated electrode and a polydimethylsiloxane (PDMS) microfluidic channel are placed on a lithium niobate chip. The arcuate interdigitated electrode is mainly formed by an interdigitated electrode being asymmetrically bent from a straight line into an arcuate curve. Two electrode ends of the arcuate interdigitated electrodes are asymmetrically arranged with one end big and another end small. The PDMS microfluidic channel includes a main flow channel, two inlet ends, and multiple outlet ends. The main flow channel is an approximately arcuate flow channel arranged around an outer side of the arcuate interdigitated electrode. Particles are patterned in a coverage section of surface acoustic waves to complete separation of microparticles.

Ultrasonic transmitting elements in an electroacoustical transceiver transmit acoustic energy to an electroacoustical transponder, which includes ultrasonic receiving elements to convert the acoustic energy into electrical power for the purposes of powering one or more sensors that are electrically coupled to the electroacoustical transponder. The electroacoustical transponder transmits data collected by the sensor(s) back to the electroacoustical transceiver wirelessly, such as through impedance modulation or electromagnetic waves. A feedback control loop can be used to adjust system parameters so that the electroacoustical transponder operates at an impedance minimum. An implementation of the system can be used to collect data in a vehicle, such as the tire air pressure. Another implementation of the system can be used to collect data in remote locations, such as in pipes, enclosures, in wells, or in bodies of water.

The invention relates to a phaco driver system for controlling operation of an ophthalmic surgical phacoemulsification device. The phaco driver system comprises a resonant output circuit for generating a transducer voltage for driving an ultrasonic transducer of the ophthalmic surgical phacoemulsification device. Further, the phaco driver system includes a bridge unit for generating a bridge output signal for feeding the resonant output circuit, the bridge output signal being based on a composition of the first and second phase signals having a fixed mutual phase difference.

A haptic stimulator includes a multilayer sheet with a piezoelectric or electroactive polymer layer adapted to mechanically deform upon application of voltage, the multilayer sheet secured to a substrate, and a source of electrical stimulation coupled to drive electrodes on the polymer layer with an AC signal to vibrate the polymer layer. In particular embodiments, the polymer contains polyvinylidene fluoride, and electrodes are patterned to control local electric fields. Another haptic stimulator has first and second electrodes with an air gap and an insulating sheet between first and second electrodes, with an AC voltage driver connecting to the electrodes. In a method of providing haptic stimulation to skin an alternating current supply drives first and second electrodes, the electrodes disposed upon either a piezoelectric or electroactive polymer sheet, vibrating the polymer layer by driving the electrodes; and coupling vibrations of the polymer layer to the sensate skin.